Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › granisetron

granisetron

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of granisetron

14 trials tracked of granisetron: 8 in phase 3 or 4.

14Trials tracked
8Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 3 6 Phase 2 4 Other / NA 2
  1. Phase 4 Pharmacogenomics and Post-Operative Nausea and Vomiting Completed
  2. Phase 4 A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Completed
  3. Phase 3 Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation Completed
  4. Phase 3 Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial Completed
  5. Phase 3 Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy Completed
  6. Phase 3 Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy Completed
Show 8 more trials
  1. Phase 3 Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED) Completed
  2. Phase 3 Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy Completed
  3. Phase 2 Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting Completed
  4. Phase 2 R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma Completed
  5. Phase 2 Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Completed
  6. Phase 2 E7 TCR T Cells for Human Papillomavirus-Associated Cancers Completed
  7. N/A Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant Completed
  8. N/A Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis Completed

Showing the 14 most-cited and recently-updated of 14 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Network meta-analysis compares 5-HT3 antagonists with or without dexamethasone for highly emetogenic chemotherapy-induced nausea and vomiting
Oncology Meta-analysis
Network meta-analysis compares 5-HT3 antagonists with or without dexamethasone for highly emetogenic chemotherapy-induced nausea and vomiting New analysis suggests palonosetron plus dexamethasone may reduce delayed vomiting in chemotherapy patients
This network meta-analysis evaluated 5-hydroxytryptamine-3 (5-HT3) receptor antagonists with or without dexamethasone in patients undergoing…
Combining palonosetron with dexamethasone reduces delayed vomiting in chemotherapy patients better than other common drug options.
Apr 9, 2026